๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nektar Therapeutics (NKTR)
NASDAQ: NKTR ยท Real-Time Price ยท USD
30.20
-2.34 (-7.19%)
Nov 20, 2026, 4:00 PM EST - Market closed

Nektar Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
52.1955.2398.4390.1292.06101.91
Revenue Growth
-16.64%-43.89%9.21%-2.10%-9.67%-33.36%
Gross Profit
52.1955.2367.7456.3570.4277.01
Operating Income
-158.42-130.77-129.92-135.23-240.24-446.1
Net Income
-177.26-164.08-118.96-276.06-368.2-523.84
Earnings Per Share
-6.31-9.73-8.68-21.79-29.55-42.90
EPS Growth
------

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
-1.3811.489.8410.11
Rest of World
55.2397.0578.6482.2191.79
Total
55.2398.4390.1292.06101.91

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
952.86245.75269.1329.44504.98798.78
Total Debt
128.67148.91194.34230.4286.87338.6
Net Cash (Debt)
824.1996.8474.7699.04218.1460.18
Net Cash Growth
699.18%29.55%-24.52%-54.59%-52.61%-45.73%
Net Cash Per Share
29.335.745.457.8217.4837.66

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-256.96-208.51-175.71-192.61-304.01-412.66
Capital Expenditures
-1.23-0.87-1.47-0.87-5.68-14.99
Free Cash Flow
-258.18-209.38-177.18-193.47-309.68-427.65
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%68.82%62.53%76.50%75.57%
Operating Margin
-303.57%-236.77%-131.99%-150.05%-260.97%-437.76%
Pretax Margin
-339.44%-297.32%-121.10%-306.54%-396.48%-513.49%
Profit Margin
-339.67%-297.07%-120.86%-306.31%-399.98%-514.03%
FCF Margin
-494.74%-379.09%-180.01%-214.68%-336.41%-419.65%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-15.8815.8815.8815.8815.88
PS Ratio
19.8015.571.741.204.6124.47